Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2067999rdf:typepubmed:Citationlld:pubmed
pubmed-article:2067999lifeskim:mentionsumls-concept:C0030664lld:lifeskim
pubmed-article:2067999lifeskim:mentionsumls-concept:C0080103lld:lifeskim
pubmed-article:2067999lifeskim:mentionsumls-concept:C0040136lld:lifeskim
pubmed-article:2067999lifeskim:mentionsumls-concept:C0205462lld:lifeskim
pubmed-article:2067999lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:2067999lifeskim:mentionsumls-concept:C0008902lld:lifeskim
pubmed-article:2067999lifeskim:mentionsumls-concept:C0441704lld:lifeskim
pubmed-article:2067999pubmed:issue2-3lld:pubmed
pubmed-article:2067999pubmed:dateCreated1991-8-15lld:pubmed
pubmed-article:2067999pubmed:abstractTextIn order to test its potential application to thyroid tumour pathology, the monoclonal antibody Ki-67 was used to demonstrate immunohistochemically proliferating cells in 31 non neoplastic and neoplastic lesions of the thyroid. Twenty benign lesions were negative. Of the 11 malignant tumors, 4 papillary, 2 follicular and 1 medullary carcinomas were also negative; only 3 follicular and 1 medullary carcinomas were positive. Moreover, no correlation was found between Ki-67 immunostaining status and histological typing or pTNM pathological classification in the 11 malignant tumors.lld:pubmed
pubmed-article:2067999pubmed:languageenglld:pubmed
pubmed-article:2067999pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2067999pubmed:citationSubsetIMlld:pubmed
pubmed-article:2067999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2067999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2067999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2067999pubmed:statusMEDLINElld:pubmed
pubmed-article:2067999pubmed:monthMarlld:pubmed
pubmed-article:2067999pubmed:issn0344-0338lld:pubmed
pubmed-article:2067999pubmed:authorpubmed-author:BogomoletzW...lld:pubmed
pubmed-article:2067999pubmed:authorpubmed-author:RigaudCClld:pubmed
pubmed-article:2067999pubmed:issnTypePrintlld:pubmed
pubmed-article:2067999pubmed:volume187lld:pubmed
pubmed-article:2067999pubmed:ownerNLMlld:pubmed
pubmed-article:2067999pubmed:authorsCompleteYlld:pubmed
pubmed-article:2067999pubmed:pagination198-200lld:pubmed
pubmed-article:2067999pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2067999pubmed:meshHeadingpubmed-meshheading:2067999-...lld:pubmed
pubmed-article:2067999pubmed:meshHeadingpubmed-meshheading:2067999-...lld:pubmed
pubmed-article:2067999pubmed:meshHeadingpubmed-meshheading:2067999-...lld:pubmed
pubmed-article:2067999pubmed:meshHeadingpubmed-meshheading:2067999-...lld:pubmed
pubmed-article:2067999pubmed:meshHeadingpubmed-meshheading:2067999-...lld:pubmed
pubmed-article:2067999pubmed:year1991lld:pubmed
pubmed-article:2067999pubmed:articleTitleApparent lack of usefulness of monoclonal antibody Ki-67 in thyroid tumour pathology. Relation to histological typing and classification.lld:pubmed
pubmed-article:2067999pubmed:affiliationLaboratoire d'Anatomie Pathologique, Institut Jean Godinot, Reims, France.lld:pubmed
pubmed-article:2067999pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2067999lld:pubmed